Situational assessment and epidemiology of HIV, HBV and HCV among people who use and inject drugs in Ghana.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2024
2024
Historique:
received:
05
03
2024
accepted:
06
06
2024
medline:
27
8
2024
pubmed:
26
8
2024
entrez:
26
8
2024
Statut:
epublish
Résumé
People who inject drugs (PWID) and people who use drugs (PWUD) are an important population group that remain under-served in Ghana. Though PWID and PWUD are among the key populations most-at-risk to acquire sexually transmitted or blood-borne diseases, they are among those with the least access to human immunodeficiency (HIV), hepatitis B (HBV) and hepatitis C (HCV) viruses' prevention, care and treatment services in Ghana due to lack of data on them. We provide a rapid assessment of the PWUD and PWID situation in Ghana. This rapid cross-sectional design undertook consultative meetings between the study team and relevant stakeholders, including Civil Society Organizations (CSO) working with PWUD/PWID. The assessment considered a representative sample of PWID and PWUD. It was conducted in four (4) selected regions of Ghana (Greater Accra, Ashanti, Western, and Northern). Overall, 323 participants were interviewed using respondent-driven sampling (RDS) approach. Information obtained from participants were demographics, HIV risk behaviors, human immunodeficiency (HIV) and sexually transmitted infections (STI)-related knowledge HIV/HCV/HBV screening, attitude, and practices among others. Analyses were conducted using Stata version 17 and RDSAT version 7.1.46 software. Drug use was found to be more prevalent among the youth with a median age of 37 years. Majority of the respondents were males (86%). About 28% of the female respondents identified themselves as sex workers, while about 74% have been involved in transactional sex. The median age at which respondents started using and injecting drugs was 20 and 22 years respectively. Majority (68%) of the respondents consume drugs through smoking, with 20% through snorting, inhaling or swallowing and 12% through injection. The drug mostly used among the respondents was heroin (52%). The most commonly injected drug was cocaine (55%). About 64.7% of respondents reported mixing two or more drugs. HIV prevalence among respondents was 2.5%, 12.3% among women and 17.7% among women engaged in sex work, highlighting the overlap vulnerability. The prevalence of hepatitis C was 6.0%, and Hepatitis B was 4.5%. Access to care is limited, with 63% of the respondents never been tested for HIV. These rapid assessment findings reveal the challenging conditions for people who use and inject drugs coupled with a relatively high prevalence of HIV and Hepatitis C compared to the general population. However, it also reveals that Ghana has a window of opportunity to prevent an exponential spread of HIV and Hepatitis in this population. Therefore, there is the need to implement prevention and treatment programs for HIV and hepatitis among people who use and inject drugs including essential strategies for an enabling environment in Ghana.
Identifiants
pubmed: 39186757
doi: 10.1371/journal.pone.0305923
pii: PONE-D-24-08805
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0305923Informations de copyright
Copyright: © 2024 Guure et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Drug Alcohol Abuse. 2016;42(1):98-110
pubmed: 26636885
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S176-81
pubmed: 25978485
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
Front Public Health. 2013 Nov 28;1:61
pubmed: 24350230
J Urban Health. 2003 Mar;80(1):137-46
pubmed: 12612103
J Infect Dis. 2019 Jun 5;220(1):78-90
pubmed: 30726973
BMC Infect Dis. 2019 Jan 3;19(1):1
pubmed: 30606108
Int J Drug Policy. 2016 Apr;30:116-23
pubmed: 26964902
Harm Reduct J. 2021 Jan 6;18(1):1
pubmed: 33407500
AIDS Behav. 2019 Oct;23(10):2641-2653
pubmed: 31297684
Harm Reduct J. 2014 Feb 13;11:5
pubmed: 24520914
Curr Opin HIV AIDS. 2012 Jul;7(4):345-53
pubmed: 22678489
Interdiscip Perspect Infect Dis. 2022 Sep 1;2022:2544481
pubmed: 36092389
Ann Gen Psychiatry. 2018 May 04;17:16
pubmed: 29755578
Braz J Psychiatry. 2012 Oct;34(3):294-305
pubmed: 23429775
HIV Med. 2015 Mar;16(3):137-51
pubmed: 25124393
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S124-30
pubmed: 25723976
Dev Psychopathol. 2018 Feb;30(1):315-335
pubmed: 28558858
Subst Use Misuse. 2006;41(6-7):1029-44
pubmed: 16809185
Braz J Psychiatry. 2013 Jul-Sep;35(3):221-30
pubmed: 24068301
PLoS One. 2017 May 18;12(5):e0177922
pubmed: 28542366
BMC Infect Dis. 2008 Jan 02;8:1
pubmed: 18171470
J Fam Issues. 2018 Jan;39(1):3-27
pubmed: 29307947
Arch Public Health. 2018 Sep 17;76:51
pubmed: 30237881
J Viral Hepat. 2019 Jul;26(7):926-929
pubmed: 30809876
PLoS One. 2013 Jun 25;8(6):e67062
pubmed: 23825620
J Gastroenterol Hepatol. 2015 Aug;30(8):1237-45
pubmed: 25708186
Drug Alcohol Depend. 2019 May 1;198:28-33
pubmed: 30877954
J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):420-7
pubmed: 26226249
HIV AIDS (Auckl). 2020 Sep 18;12:441-448
pubmed: 32982471
J Int AIDS Soc. 2015 May 22;18:19888
pubmed: 26004637
Am J Public Health. 2010 Aug;100(8):1449-53
pubmed: 20558797
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207
pubmed: 29074409
Addiction. 2015 Apr;110(4):627-35
pubmed: 25510264